Within the past year, many lawsuits have been filed against Teva Pharmaceuticals. These suits allege that Teva’s Paragard IUD fractures upon removal, resulting in fragments being left in the uterus. The plaintiffs claimed this caused them to undergo additional removal procedures, which would have been unnecessary had this defect not occurred. The purpose of this page is to provide a status update on the current state of the Paragard lawsuits as of late January 2021. Other Paragard law firms and websites are providing updates on this litigation, and I would encourage you to follow them here, here, and here.
Certainly, the biggest news in the short history of this litigation was last month when these lawsuits were centralized into an MDL in Georgia federal court. This means there will be a class action in which all federal court cases will be consolidated in Georgia under one judge. So if you have a federal case in California, Texas, Florida, or anywhere, it will end up.
Let’s start out by talking about some of the science behind these cases. Usually, what fuels litigation is that studies come out and lawyers jump on these studies to bring lawsuits. In this litigation, it might be a little bit backward. It took a while for plaintiffs’ lawyers to pick up on the problems with Paragard. Now a new study this year further supports the contention Paragard lawyers are making.